Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct;8(10):1277-91.
doi: 10.1517/17425255.2012.708337. Epub 2012 Jul 18.

Ocular toxicity from systemically administered xenobiotics

Affiliations
Review

Ocular toxicity from systemically administered xenobiotics

Mitan R Gokulgandhi et al. Expert Opin Drug Metab Toxicol. 2012 Oct.

Abstract

Introduction: The eye is considered as the most privileged organ because of the blood-ocular barrier that acts as a barrier to systemically administered xenobiotics. However, there has been a significant increase in the number of reports on systemic drug-induced ocular complications. If such complications are left untreated, then it may cause permanent damage to vision. Hence, knowledge of most recent updates on ever-increasing reports of such toxicities has become imperative to develop better therapy while minimizing toxicities.

Areas covered: The article is mainly divided into anterior and posterior segment manifestations caused by systemically administered drugs. The anterior segment is further elaborated on corneal complications where as the posterior segment is focused on optic nerve, retinal and vitreous complications. Furthermore, this article includes recent updates on acute and chronic ocular predicaments, in addition to discussing various associated symptoms caused by drugs.

Expert opinion: Direct correlation of ocular toxicities due to systemic drug therapy is evident from current literature. Therefore, it is necessary to have detailed documentation of these complications to improve understanding and predict toxicities. We made an attempt to ensure that the reader is aware of the characteristic ocular complications, the potential for irreversible drug toxicity and indications for cessation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Corneal epithelial microcysts visible with direct slit-beam illumination. Reproduced with permission of Nature Publishing Group from Lochhead et al. [29].
Figure 2
Figure 2
(Left) An optic nerve appearance in non-arteritic ischemic optic neuropathy. (Right) An optic nerve in amiodarone induced optic neuropathy has a similar appearance. Reproduced with permission of Elsevier from Macaluso et al. [76].

Similar articles

Cited by

References

    1. Brick DC. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol. 1995;40(3):232–6. - PubMed
    1. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67(1):75–93. An important review highlighting several retrospective cases and reported adverse effects. - PubMed
    1. Moorthy RS, Valluri S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol. 1999;10(6):438–46. This article highlights some of the systemic drug induced ocular side effects. - PubMed
    1. Blomquist PH. Ocular complications of systemic medications. Am J Med Sci. 2011;342(1):62–9. Focus on common ocular side effects are discussed. - PubMed
    1. Garralda Luquin A. Ocular toxicity induced by medication. An Sist Sanit Navar. 2008;31(Suppl 3):147–53. - PubMed

Publication types